Pharmafile Logo
Pharmafocus logo
Advanced Search
Novartis

FDA rejects Novartis’ Ilaris for gouty arthritis

June 22, 2011
Research and Development Ilaris, Novartis, gouty arthritis

An FDA advisory panel has voted against backing Novartis’ Ilaris for gouty arthritis because of safety concerns. Ilaris (canakinumab) is …

News

Careers in next generation contract partnering

June 22, 2011
Business Services, Manufacturing and Production, Research and Development contract manufacturing, contract research, cros

Over the past few years, a significant shift has occurred in the depth and type of relations that the pharma …

Feature
Neurotune chief executive Bruno Oesch

Working Life: Neurotune’s chief executive

June 22, 2011
Business Services, Research and Development Working Life, recruitment

Bruno Oesch, chief executive of Swiss biopharmaceutical company Neurotune, talks to Pharmafocus about being at the interface of science and …

News
biosector_2_david_kane

David Kane to lead CCC’s Biosector 2

June 22, 2011
Medical Communications appointment, medical communications

Chandler Chicco Companies (CCC) has appointed David Kane as managing director of its healthcare PR agency Biosector 2. He moves …

Appointment

Health research charities hit back at animal rights campaign

June 21, 2011
Medical Communications Animal testing, Animal tests, Cancer Research UK, animal activists

Four of the UK’s leading health research charities have hit back after being accused of funding “horrific animal experiments” by …

News
Pfizer

FDA approves Pfizer pain drug Oxecta

June 21, 2011
Sales and Marketing FDA, Oxecta, Pfizer, chronic pain

The FDA has approved Pfizer and Acura’s novel pain drug Oxecta, but will require follow up studies to prove its …

News

NICE gains expanded role alongside value-based pricing

June 21, 2011
Sales and Marketing NHS reforms, NICE, value-based pricing

NICE will be given a wider remit to oversee social care and its guidance used alongside value-based pricing as part …

News

NICE backs Celgene’s thalidomide and Janssen’s Velcade

June 21, 2011
Sales and Marketing NICE, Thalidomide, Velcade, multiple myeloma

Celgene’s thalidomide and Janssen-Cilag’s Velcade have been given the thumbs up by NICE as a treatment for a cancer that …

News

Pfizer project is quality-by-design milestone for FDA and EMA

June 21, 2011
Manufacturing and Production EMA, FDA, Quality by Design, pharma manufacturing news

A pilot project set up earlier this year to encourage the adoption of quality-by-design in pharmaceutical manufacturing has passed its …

News

Novartis breaks ground on $500m Russian facility

June 21, 2011
Manufacturing and Production Novartis, Russia, pharma manufacturing news

Novartis has started construction of its new pharmaceutical manufacturing plant in St. Petersburg, Russia.The company has broken ground on the …

News

Dr Reddy’s API plant in Mexico under FDA scrutiny

June 21, 2011
Manufacturing and Production APIs, Dr Reddy's, FDA, GMP violations, pharma manufacturing news

Indian drugmaker Dr Reddy’s Laboratories has been sent a warning letter by the US FDA after a manufacturing facility in …

News
interlace_global_john_gill

Interlace Global Group appoints ten new staff

June 21, 2011
Medical Communications apppointment, medical communications

Interlace Global Group has expanded the client services and editorial teams at its twin companies Wells Healthcare and Interlace Global …

Appointment

Smelly Risperdal adds to J&J’s recall tally

June 20, 2011
Manufacturing and Production John Lechleiter, pharma manufacturing news, recalls

Johnson & Johnson continues to be plagued by product recalls, with the latest involving two lots of its schizophrenia drug …

News

NICE guideline helping to cut referrals

June 20, 2011
GSK, NICE, bph

A NICE guideline on treating lower urinary tract symptoms (LUTS) in men is helping to cut referrals to urologists, thereby …

News
rocheroof

Mid-stage trial boost for Roche skin cancer drug vismodegib

June 20, 2011
Research and Development Cancer, Roche, skin cancer, vismodegib

Roche’s novel skin cancer drug vismodegib has met its primary endpoint in a phase II trial. Vismodegib is an investigational, …

News

GlaxoSmithKline expands Canadian manufacturing plant

June 20, 2011
Manufacturing and Production GSK, pharma manufacturing news

GlaxoSmithKline has set aside almost £19 million ($31 million) to expand a manufacturing facility in Ontario, Canada, creating 70 additional …

News
Cost-effectiveness assessment body NICE

NICE reprieved by government U-turn

June 20, 2011
Sales and Marketing Health and Social Care Bill, NICE, value-based pricing

The government has performed an unexpected U-turn by allowing NICE to retain its powers to decide which new drugs the …

News

Double Helix appoints Sarah Frere-Cook and Ginevra Drinka

June 20, 2011
Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing

Double Helix has boosted its London-based strategic market research team with two new appointments. Sarah Frere-Cook joins as a research …

Appointment

Actelion plans biotech start-up

June 20, 2011
Research and Development Actelion, biotech

Swiss biopharmaceutical company Actelion is planning to launch a biotech start-up that would run separately from the main company. It …

News

Europe slower than US to approve new cancer drugs

June 17, 2011
Sales and Marketing EMA, FDA, FDA approvals, new drug approvals

The European Medicines Agency approves fewer new oncology drugs than its US counterpart and takes nearly twice as long to …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026